Published in Transplant Proc on August 01, 2003
Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients. PLoS One (2015) 0.75
Medical Management of Metabolic Complications of Liver Transplant Recipients. Gastroenterol Hepatol (N Y) (2016) 0.75
A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med (1996) 3.44
Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med (1991) 3.14
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol (2012) 2.96
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology (1996) 2.47
Inflammation and liver cancer: new molecular links . Ann N Y Acad Sci (2009) 2.29
Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis. Hepatology (2000) 2.24
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol (2000) 2.22
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev (2010) 2.09
New therapies for hepatocellular carcinoma. Oncogene (2006) 2.05
Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) (2011) 2.00
Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology (1993) 1.95
Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut (2000) 1.82
Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents. J Hepatol (2000) 1.73
Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology (1998) 1.67
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
The problem of aging human remains and living individuals: a review. Forensic Sci Int (2009) 1.59
Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma. Hepatology (2001) 1.56
Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology (1996) 1.56
Repair of ventral hernias with expanded polytetrafluoroethylene patch. Br J Surg (1998) 1.50
Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl (2001) 1.44
Magnesium binding to the bacterial chemotaxis protein CheY results in large conformational changes involving its functional surface. J Mol Biol (1994) 1.44
Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr Gene Ther (2003) 1.42
Rituximab in CD20 positive multiple myeloma. Leukemia (2007) 1.40
[Resistance of Mycobacterium tuberculosis in the province of Castellón]. Arch Bronconeumol (1996) 1.40
[In re the therapeutic aspects of the carcinoid syndrome]. Rev Esp Enferm Dig (1992) 1.39
Liver transplantation in cirrhotic patients over 60 years of age. Rev Esp Enferm Dig (1998) 1.38
Risk of recurrent spontaneous abortion for pregnancies discovered in the fifth week of gestation. Lancet (1994) 1.37
Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation (2001) 1.34
Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med (Berl) (2009) 1.33
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model. Antimicrob Agents Chemother (2002) 1.32
Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology (1994) 1.32
Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl (2001) 1.31
Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus. Horm Metab Res (2007) 1.31
Müllerian defects in women with normal reproductive outcome. Fertil Steril (1991) 1.29
Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology (1997) 1.25
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl (2001) 1.25
Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon. J Hepatol (1994) 1.25
Totally laparoscopic full left hepatectomy for living donor liver transplantation in adolescents and adults. Am J Transplant (2013) 1.20
Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology (1989) 1.20
The celiac axis compression syndrome (CACS): critical review in the laparoscopic era. Rev Esp Enferm Dig (2010) 1.19
Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology. Immunol Rev (1990) 1.18
Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation (2001) 1.18
Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones. Antimicrob Agents Chemother (2001) 1.18
Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. J Immunol (2000) 1.17
Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1993) 1.16
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol (2010) 1.15
Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. Oncogene (2008) 1.15
Transmission of hepatitis C virus infection to tree shrews. Virology (1998) 1.14
Surgical complications in the postoperative period of liver transplantation in children. Transplant Proc (1984) 1.13
Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cell Immunol (1992) 1.12
Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology (1992) 1.10
Amphiregulin: a new growth factor in hepatocarcinogenesis. Cancer Lett (2007) 1.08
Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol (1998) 1.07
Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety. Am J Transplant (2013) 1.07
Identification of a novel adhesion molecule in human leukocytes by monoclonal antibody LB-2. FEBS Lett (1987) 1.05
Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology (1993) 1.05
Liver cytoprotection by prostaglandins. Pharmacol Ther (1993) 1.05
Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology (2001) 1.04
Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes (1999) 1.04
Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology (1995) 1.03
Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats. Gut (2006) 1.02
Nutrition, health and social factors related to intellectual performance. World Rev Nutr Diet (1974) 1.02
Thermodynamic analysis of the chemotactic protein from Escherichia coli, CheY. Biochemistry (1993) 1.02
Giant jejunoileal duplication: prenatal diagnosis and complete excision without intestinal resection. J Pediatr Surg (1993) 1.02
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma. Cancer Gene Ther (2010) 1.02
The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol (1991) 1.02